1 |
Barcellona D, Mameli A, Cornacchini S, Perra F, Diovaldi M, Farci N, Moledda V, Marongiu F. Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants. Int J Cardiol 2021;333:162-6. [PMID: 33705844 DOI: 10.1016/j.ijcard.2021.03.003] [Reference Citation Analysis]
|
2 |
Rivolo S, Di Fusco M, Polanco C, Kang A, Dhanda D, Savone M, Skandamis A, Kongnakorn T, Soto J. Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain. PLoS One 2021;16:e0259251. [PMID: 34767564 DOI: 10.1371/journal.pone.0259251] [Reference Citation Analysis]
|
3 |
Calderon JM, Martinez F, Diaz J, Fernandez A, Sauri I, Uso R, Trillo JL, Vela S, Bea C, Redon J, Forner MJ. Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation. Front Cardiovasc Med 2022;8:733300. [DOI: 10.3389/fcvm.2021.733300] [Reference Citation Analysis]
|